Barriers and Facilitators to MMR Vaccination Among Healthcare Workers
NCT06456788 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23
Last updated 2025-05-06
Summary
Measles is a highly contagious disease which can result in severe complications in some patients. Healthcare workers have a higher risk of getting measles than the general population because of their increased risk of exposure from patients with measles attending hospitals. Having had measles in the past or at least one dose of the measles, mumps and rubella (MMR) vaccine provides protection (immunity) against measles. UK government guidelines therefore recommend that healthcare workers and non-clinical staff with direct patient contact are fully vaccinated or have other evidence of immunity. Yet, evidence from recent measles outbreaks suggests that some healthcare workers are not immune or do not know if they are immune, with implications for containment efforts, cost and transmission. The purpose of this study is to identify barriers and facilitators to uptake of the MMR vaccine among healthcare workers at King's College Hospital NHS Foundation Trust (KCH). KCH healthcare workers will be eligible to take part in the study if they are aged 18 and over and have direct contact with patients. In addition, the research will focus on four subgroups of healthcare workers at KCH: those who are not immune, those who have not completed the full vaccination schedule, those who don't know their immunity status, those received the vaccine only after joining KCH. The latter may provide insights into facilitators to vaccine uptake. Measles immunity forms part of the occupational health screening at KCH. A series of semi structured interviews lasting approximately 1 hour will explore participants' experiences of the occupational health vaccine screening process and measles vaccine campaigns at KCH; why they are unvaccinated/not fully vaccinated/do not know if they are immune/decided to be vaccinated after joining KCH; and what measures or interventions may help healthcare workers when deciding whether to get the MMR vaccine.
Conditions
Interventions
- BIOLOGICAL
-
MMR vaccination
MMR vaccination status
Sponsors & Collaborators
-
King's College Hospital NHS Trust
collaborator OTHER -
UK Health Security Agency
collaborator UNKNOWN - lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-12
- Primary Completion
- 2024-12-19
- Completion
- 2024-12-19
Countries
- United Kingdom
Study Locations
More Related Trials
-
Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?
NCT04445610 ·Status: UNKNOWN
-
Impact of HIV on Measles and Measles Immunisation
NCT00247091 ·Status: COMPLETED
-
Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children
NCT05758532 ·Status: RECRUITING ·Phase: PHASE4
-
A Tool Kit to Improve Vaccine Confidence in the Philippines
NCT06218368 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed
NCT05592756 ·Status: COMPLETED
-
The Effect of ShotBlocker on Pain and Satisfaction During Measles-Rubella-Mumps Vaccination
NCT06762938 ·Status: COMPLETED ·Phase: NA
-
Increasing Vaccine Uptake Among Adolescents in the Rural South
NCT04999267 ·Status: COMPLETED ·Phase: NA
-
A Survey of Acceptance and Factors Associated With Hesitancy Vaccination in Northeast Brazil
NCT06675721 ·Status: NOT_YET_RECRUITING
-
Unravelling the Measles Paradox in Children
NCT06923631 ·Status: NOT_YET_RECRUITING
-
Intervention to Promote Childhood Vaccinations and Influence Vaccination Attitudes
NCT05425823 ·Status: COMPLETED ·Phase: NA
-
A Second Dose of Measles Vaccine (MV) in the Second Year of Life
NCT02943681 ·Status: COMPLETED ·Phase: NA
-
Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial
NCT02904642 ·Status: COMPLETED ·Phase: NA
-
Investigation of Immune Amnesia Following Measles Infection in Select African Regions
NCT06153979 ·Status: COMPLETED
-
Non-Specific Effects of Standard Titre Measles Vaccination
NCT00168662 ·Status: COMPLETED ·Phase: PHASE4
-
Healthy, Immunized Communities Study
NCT03854734 ·Status: COMPLETED ·Phase: NA
-
Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries?
NCT04468802 ·Status: COMPLETED
-
Vaccination Coverage and Uptake in Young People Experiencing or at Risk of Homelessness
NCT04864678 ·Status: COMPLETED
-
Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years
NCT00891007 ·Status: COMPLETED ·Phase: PHASE2
-
Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial
NCT05803538 ·Status: UNKNOWN ·Phase: NA
-
Testing the Use of Prompts to Increase Adolescent Immunization Rates
NCT01984125 ·Status: COMPLETED ·Phase: NA
-
The Interaction Between Measles and DTP Vaccination
NCT02710045 ·Status: COMPLETED ·Phase: NA
-
Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.
NCT01668745 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Pediatric Measles Cases in 2019: Single-Center Experience
NCT05614791 ·Status: COMPLETED
-
Measles and BCG Vaccines for Mother and Child
NCT04899765 ·Status: RECRUITING ·Phase: PHASE4
-
Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years
NCT00161863 ·Status: COMPLETED ·Phase: PHASE3